Literature DB >> 34650270

Deletion and replacement of long genomic sequences using prime editing.

Tingting Jiang1, Xiao-Ou Zhang2,3, Zhiping Weng2, Wen Xue4,5,6,7.   

Abstract

Genomic insertions, duplications and insertion/deletions (indels), which account for ~14% of human pathogenic mutations, cannot be accurately or efficiently corrected by current gene-editing methods, especially those that involve larger alterations (>100 base pairs (bp)). Here, we optimize prime editing (PE) tools for creating precise genomic deletions and direct the replacement of a genomic fragment ranging from ~1 kilobases (kb) to ~10 kb with a desired sequence (up to 60 bp) in the absence of an exogenous DNA template. By conjugating Cas9 nuclease to reverse transcriptase (PE-Cas9) and combining it with two PE guide RNAs (pegRNAs) targeting complementary DNA strands, we achieve precise and specific deletion and repair of target sequences via using this PE-Cas9-based deletion and repair (PEDAR) method. PEDAR outperformed other genome-editing methods in a reporter system and at endogenous loci, efficiently creating large and precise genomic alterations. In a mouse model of tyrosinemia, PEDAR removed a 1.38-kb pathogenic insertion within the Fah gene and precisely repaired the deletion junction to restore FAH expression in liver.
© 2021. The Author(s), under exclusive licence to Springer Nature America, Inc.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34650270      PMCID: PMC8847310          DOI: 10.1038/s41587-021-01026-y

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   68.164


  41 in total

Review 1.  Active human retrotransposons: variation and disease.

Authors:  Dustin C Hancks; Haig H Kazazian
Journal:  Curr Opin Genet Dev       Date:  2012-03-08       Impact factor: 5.578

2.  Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity.

Authors:  F Ann Ran; Patrick D Hsu; Chie-Yu Lin; Jonathan S Gootenberg; Silvana Konermann; Alexandro E Trevino; David A Scott; Azusa Inoue; Shogo Matoba; Yi Zhang; Feng Zhang
Journal:  Cell       Date:  2013-08-29       Impact factor: 41.582

3.  Cardiologists send up a trial balloon in new efforts to relieve heart failure.

Authors:  M F Goldsmith
Journal:  JAMA       Date:  1987-01-16       Impact factor: 56.272

Review 4.  A systematic analysis of LINE-1 endonuclease-dependent retrotranspositional events causing human genetic disease.

Authors:  Jian-Min Chen; Peter D Stenson; David N Cooper; Claude Férec
Journal:  Hum Genet       Date:  2005-06-28       Impact factor: 4.132

Review 5.  The impact of retrotransposons on human genome evolution.

Authors:  Richard Cordaux; Mark A Batzer
Journal:  Nat Rev Genet       Date:  2009-10       Impact factor: 53.242

6.  Identification of pathogenic retrotransposon insertions in cancer predisposition genes.

Authors:  Yaping Qian; Debora Mancini-DiNardo; Thaddeus Judkins; Hannah C Cox; Krystal Brown; Maria Elias; Nanda Singh; Courtney Daniels; Jayson Holladay; Bradford Coffee; Karla R Bowles; Benjamin B Roa
Journal:  Cancer Genet       Date:  2017-08-24

Review 7.  Roles for retrotransposon insertions in human disease.

Authors:  Dustin C Hancks; Haig H Kazazian
Journal:  Mob DNA       Date:  2016-05-06

8.  Human Retrotransposon Insertion Polymorphisms Are Associated with Health and Disease via Gene Regulatory Phenotypes.

Authors:  Lu Wang; Emily T Norris; I K Jordan
Journal:  Front Microbiol       Date:  2017-08-02       Impact factor: 5.640

9.  Creation of mutant mice with megabase-sized deletions containing custom-designed breakpoints by means of the CRISPR/Cas9 system.

Authors:  Tomoko Kato; Satoshi Hara; Yuji Goto; Yuya Ogawa; Haruka Okayasu; Souichirou Kubota; Moe Tamano; Miho Terao; Shuji Takada
Journal:  Sci Rep       Date:  2017-03-03       Impact factor: 4.379

10.  ClinVar: public archive of relationships among sequence variation and human phenotype.

Authors:  Melissa J Landrum; Jennifer M Lee; George R Riley; Wonhee Jang; Wendy S Rubinstein; Deanna M Church; Donna R Maglott
Journal:  Nucleic Acids Res       Date:  2013-11-14       Impact factor: 16.971

View more
  12 in total

Review 1.  Designing and executing prime editing experiments in mammalian cells.

Authors:  Jordan L Doman; Alexander A Sousa; Peyton B Randolph; Peter J Chen; David R Liu
Journal:  Nat Protoc       Date:  2022-08-08       Impact factor: 17.021

Review 2.  Developing Bottom-Up Induced Pluripotent Stem Cell Derived Solid Tumor Models Using Precision Genome Editing Technologies.

Authors:  Kelsie L Becklin; Garrett M Draper; Rebecca A Madden; Mitchell G Kluesner; Tomoyuki Koga; Miller Huang; William A Weiss; Logan G Spector; David A Largaespada; Branden S Moriarity; Beau R Webber
Journal:  CRISPR J       Date:  2022-08

3.  A competitive precision CRISPR method to identify the fitness effects of transcription factor binding sites.

Authors:  Päivi Pihlajamaa; Otto Kauko; Biswajyoti Sahu; Teemu Kivioja; Jussi Taipale
Journal:  Nat Biotechnol       Date:  2022-09-26       Impact factor: 68.164

Review 4.  CRISPR-based genome editing through the lens of DNA repair.

Authors:  Tarun S Nambiar; Lou Baudrier; Pierre Billon; Alberto Ciccia
Journal:  Mol Cell       Date:  2022-01-20       Impact factor: 17.970

5.  WT-PE: Prime editing with nuclease wild-type Cas9 enables versatile large-scale genome editing.

Authors:  Rui Tao; Yanhong Wang; Yun Hu; Yaoge Jiao; Lifang Zhou; Lurong Jiang; Li Li; Xingyu He; Min Li; Yamei Yu; Qiang Chen; Shaohua Yao
Journal:  Signal Transduct Target Ther       Date:  2022-04-20

Review 6.  Improvements of nuclease and nickase gene modification techniques for the treatment of genetic diseases.

Authors:  Yaoyao Lu; Cedric Happi Mbakam; Bo Song; Eli Bendavid; Jacques-P Tremblay
Journal:  Front Genome Ed       Date:  2022-07-26

Review 7.  Precise somatic genome editing for treatment of inborn errors of immunity.

Authors:  Qingzhou Meng; Haixiang Sun; Jianghuai Liu
Journal:  Front Immunol       Date:  2022-08-26       Impact factor: 8.786

Review 8.  Genome editing for primary immunodeficiencies: A therapeutic perspective on Wiskott-Aldrich syndrome.

Authors:  Asma Naseem; Zohar Steinberg; Alessia Cavazza
Journal:  Front Immunol       Date:  2022-08-18       Impact factor: 8.786

9.  Global spectrum of USH2A mutation in inherited retinal dystrophies: Prompt message for development of base editing therapy.

Authors:  Bing-Nan Su; Ren-Juan Shen; Zhuo-Lin Liu; Yang Li; Zi-Bing Jin
Journal:  Front Aging Neurosci       Date:  2022-08-10       Impact factor: 5.702

10.  Harnessing DSB repair to promote efficient homology-dependent and -independent prime editing.

Authors:  Nina Akrap; Songyuan Li; Sandra Wimberger; Martin Peterka; Pei-Pei Hsieh; Dmitrii Degtev; Burcu Bestas; Jack Barr; Stijn van de Plassche; Patricia Mendoza-Garcia; Saša Šviković; Grzegorz Sienski; Mike Firth; Marcello Maresca
Journal:  Nat Commun       Date:  2022-03-24       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.